Middle East and Africa Bioinformatics Market is segmented By Type (Knowledge Management Tools, Bioinformatics Platforms, and Services), By Application (Genomics, Proteomics, Transcriptomics and, Cheminformatics, and Others), and By Country (South Africa, U.A.E, Egypt, Saudi Arabia, Israel) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Report Overview
Middle East and Africa Bioinformatics Market is expected to grow at a CAGR of 15.7% during the forecast period 2023-2030.
Â
Bioinformatics is a branch of science that integrates computer programming, big data, and Molecular Biology to help scientists comprehend and detect patterns in biological data. It is especially valuable in genome research and DNA sequencing since it helps scientists to arrange vast volumes of data.
There are several fields of Biology to specialize in, ranging from genetics to toxicology to mycology and radiobiology. Bioinformatics is one of the fascinating topics that allows you to find, assess, store, and retrieve biological information. As an interdisciplinary topic of research, it combines applications of Computer Science, Statistics, and Biology to create software applications for interpreting biological data such as DNA sequencing, protein analysis, evolutionary genetics, and so on.
Important bioinformatics choices on drug development will be made in the future by individuals who not only understand biology but can also utilize bioinformatics tools and the information they release to create hypotheses and find excellent targets.
Middle East and Africa Bioinformatics Market Scope
|
Metrics |
Details |
|
CAGR |
15.7% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Type, Application |
|
Countries Covered |
South Africa, U.A.E, Egypt, Saudi Arabia, Israel, Rest of Middle East & Africa |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
Â
For more details on this report Request for Sample
Â
Market Growth Factors
The growing need for sequencing protein and nucleic acids, increasing government initiatives, rising help from this field in producing new medicines and clinical diagnostics, a growing number of partnerships between research organizations and companies, and a rising need for integrated bioinformatics systems in proteomics and genomics are the driving factors of the Middle East and Africa Bioinformatics market.
Market Restraint
High prices, a shortage of trained labor, a lack of user-friendly technologies, and a lack of compatibility across diverse data formats are some of the challenges of the Middle East and Africa market.
Market Opportunities
Strategic Initiatives by Market Players Creates Significant Opportunities for the Market
Bioinformatics, a branch of life science concerned with genome understanding and planning, provides useful biological information. A genome is the complex organization of genetic sets found in a cell or a living entity as a whole. Personalized medicine is a multifaceted approach to dealing with individual health care needs. Bioinformatics techniques aided in the creation of patient-specific medications.
For example, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics, and Structural Pharmacogenomics in December 2020. The investment resulted in the combined production of a series of database modules of innovative, structurally variant proteins, as well as the direct marketing of these goods to the pharmaceutical and biotechnology industries for use in the development of customized medicine.
As a result of the rising frequency of chronic illness and increased drug-resistance difficulties in conventional therapy, there is a greater need for improved bioinformatics in drug development. This is anticipated to be one of the primary factors driving market expansion over the projected period.
Middle East and Africa Bioinformatics Industry SegmentationÂ
The Middle East and Africa bioinformatics market is segmented by type, and application.
Based on application, the genomics segment is expected to dominate the market over the forecast years. It is largely attributed to different technical improvements connected with handling a large number of genomic data, as well as the growing demand for pharmacogenomics in sequence screening and medication development.
Furthermore, expanding prospects and potential relevance of genomes in clinical research are driving demand for genomics applications and enhancing the growth of the Middle East and Africa bioinformatics market.
Regional Insights
The countries covered in the Middle East and Africa bioinformatics market are South Africa, U.A.E, Egypt, Saudi Arabia, Israel, Rest of Middle East & Africa.
South Africa is expected to lead the market owing to an increase in periodontal disease prevalence, medical tourism, technical breakthroughs in bioinformatics, and increased R&D activities.
Middle East and Africa Bioinformatics Market Key PlayersÂ
Companies such as Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc., and Waters Corporation are expected to lead the Middle East and Africa bioinformatics market during the forecast period.
